X-13735074-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_003611.3(OFD1):c.3G>A(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000209 in 1,196,576 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000021 ( 0 hom. 10 hem. )
Consequence
OFD1
NM_003611.3 start_lost
NM_003611.3 start_lost
Scores
1
5
8
Clinical Significance
Conservation
PhyloP100: 0.130
Genes affected
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Start lost variant, no new inframe start found.
BS2
High Hemizygotes in GnomAdExome4 at 10 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OFD1 | NM_003611.3 | c.3G>A | p.Met1? | start_lost | 1/23 | ENST00000340096.11 | NP_003602.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OFD1 | ENST00000340096.11 | c.3G>A | p.Met1? | start_lost | 1/23 | 1 | NM_003611.3 | ENSP00000344314.6 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112510Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34650
GnomAD3 genomes
AF:
AC:
2
AN:
112510
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34650
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000314 AC: 5AN: 159173Hom.: 0 AF XY: 0.0000191 AC XY: 1AN XY: 52331
GnomAD3 exomes
AF:
AC:
5
AN:
159173
Hom.:
AF XY:
AC XY:
1
AN XY:
52331
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 23AN: 1084066Hom.: 0 Cov.: 31 AF XY: 0.0000281 AC XY: 10AN XY: 355846
GnomAD4 exome
AF:
AC:
23
AN:
1084066
Hom.:
Cov.:
31
AF XY:
AC XY:
10
AN XY:
355846
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112510Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34650
GnomAD4 genome
AF:
AC:
2
AN:
112510
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34650
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 24, 2018 | The p.M1? variant (also known as c.3G>A), located in coding exon 1 of the OFD1 gene, results from a G to A substitution at nucleotide position 3. This alters the methionine residue at the initiation codon (ATG). Sequence variations that modify the initiation codon are expected to result in either loss of translation initiation, N-terminal truncation, or cause a shift in the mRNA reading frame. However, there are in-frame methionines at amino acid positions 2 and 7 that could be used as an alternate initiation codon, and the significance of the N-terminus for this protein is not well established. In addition, this amino acid position is conserved only in primates. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Joubert syndrome 10 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Apr 02, 2018 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Familial aplasia of the vermis;C1510460:Orofaciodigital syndrome I Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 31, 2023 | This sequence change affects the initiator methionine of the OFD1 mRNA. The next in-frame methionine is located at codon 2. This variant is present in population databases (rs778840618, gnomAD 0.02%). Disruption of the initiator codon has been observed in individual(s) with clinical features of X-linked recessive primary ciliary dyskinesia (PMID: 35728977). ClinVar contains an entry for this variant (Variation ID: 1031340). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D
MetaSVM
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MutPred
Gain of catalytic residue at M1 (P = 0.0401);Gain of catalytic residue at M1 (P = 0.0401);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at